feed,title,long_url,short_url
Benzinga,Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation,https://benzinga.com/general/biotech/24/01/36800915/regeneronsanofis-largest-selling-drug-dupixent-scores-fda-approval-for-infants-with-esophagus-inf,https://da.gd/XE3Ydp
